Australian Biotech nails $940m deal with US firm

MELBOURNE: ASX-listed Dimerix has landed one of the biggest licensing deals by an Australian biotechnology

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In